Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple Myeloma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Central Arkansas Veterans Healthcare System
Little Rock, Arkansas, United States
- West Los Angeles Va Medical Center
Los Angeles, California, United States
- Edward Hines Jr Va Hospital
Hines, Illinois, United States
- Va Boston Healthcare System
Jamaica Plain, Massachusetts, United States
- Kansas City Va Medical Center
Kansas City, Missouri, United States
- Pittsburgh Va Medical Center
Pittsburgh, Pennsylvania, United States
- Houston Va Medical Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2010
- Primary completion
- 11 Sept 2017
- Completion
- 11 Sept 2017
- Last update posted
- 25 Jan 2021
- Registered enrollment
- 33
- Registry id
- NCT01380106
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.